These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20552547)

  • 1. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
    Sousa B; Paredes J; Milanezi F; Lopes N; Martins D; Dufloth R; Vieira D; Albergaria A; Veronese L; Carneiro V; Carvalho S; Costa JL; Zeferino L; Schmitt F
    Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-cadherin and vimentin are useful basal markers in breast cancers.
    Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
    Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.
    Paredes J; Lopes N; Milanezi F; Schmitt FC
    Virchows Arch; 2007 Jan; 450(1):73-80. PubMed ID: 17123107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A; Sussman ZM; Lawson D; Cohen C
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
    Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
    Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
    Bhargava R; Beriwal S; Striebel JM; Dabbs DJ
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
    Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
    Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
    Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
    Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
    J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
    Matos I; Dufloth R; Alvarenga M; Zeferino LC; Schmitt F
    Virchows Arch; 2005 Oct; 447(4):688-94. PubMed ID: 16012853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
    Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
    J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
    Ren X; Yuan L; Shen S; Wu H; Lu J; Liang Z
    Tumour Biol; 2016 Aug; 37(8):11385-95. PubMed ID: 26968553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression.
    Orlandini LF; Reis FJCD; da Silveira WA; Tiezzi MG; de Andrade JM; Ribeiro-Silva A; Deaton R; Bosland M; Tiezzi DG
    Rev Bras Ginecol Obstet; 2018 Dec; 40(12):779-786. PubMed ID: 30359996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.
    McGinn O; Riley D; Finlay-Schultz J; Paul KV; Kabos P; Sartorius CA
    Mol Cancer Res; 2022 Sep; 20(9):1443-1455. PubMed ID: 35639459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.
    Wang H; Guan B; Shi Q; Ma H; Zhou H; Wang X; Zhou X
    Med Oncol; 2011 Mar; 28(1):42-50. PubMed ID: 20041316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
    Reyes C; Jorda M; Gomez-Fernández C
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of basal cytokeratin expression in breast cancer.
    Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in triple-negative breast cancer.
    Rakha EA; El-Sayed ME; Green AR; Lee AH; Robertson JF; Ellis IO
    Cancer; 2007 Jan; 109(1):25-32. PubMed ID: 17146782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
    Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.